| Literature DB >> 27623015 |
Eduardo E Arteaga-Bracho1, Maria Gulinello2, Michael L Winchester3, Nandini Pichamoorthy3, Jenna R Petronglo3, Alicia D Zambrano4, Julio Inocencio5, Chirstopher D De Jesus1, Joseph O Louie5, Solen Gokhan3, Mark F Mehler6, Aldrin E Molero7.
Abstract
The mutation in huntingtin (mHtt) leads to a spectrum of impairments in the developing forebrain of Huntington's disease (HD) mouse models. Whether these developmental alterations are due to loss- or gain-of-function mechanisms and contribute to HD pathogenesis is unknown. We examined the role of selective loss of huntingtin (Htt) function during development on postnatal vulnerability to cell death. We employed mice expressing very low levels of Htt throughout embryonic life to postnatal day 21 (Hdhd•hyp). We demonstrated that Hdhd•hyp mice exhibit: (1) late-life striatal and cortical neuronal degeneration; (2) neurological and skeletal muscle alterations; and (3) white matter tract impairments and axonal degeneration. Hdhd•hyp embryos also exhibited subpallial heterotopias, aberrant striatal maturation and deregulation of gliogenesis. These results indicate that developmental deficits associated with Htt functions render cells present at discrete neural foci increasingly susceptible to cell death, thus implying the potential existence of a loss-of-function developmental component to HD pathogenesis.Entities:
Keywords: Degeneration; Development; Gliogenesis; Huntingtin; Huntington's disease; Loss-of-function; Maturation; Myelin; Neurogenesis; Pathogenesis
Mesh:
Substances:
Year: 2016 PMID: 27623015 PMCID: PMC5102778 DOI: 10.1016/j.nbd.2016.09.006
Source DB: PubMed Journal: Neurobiol Dis ISSN: 0969-9961 Impact factor: 5.996